comparemela.com

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Simon Latimer ,Todd Davis ,Jeffrey Rona ,Maeve Conneighton ,Nasdaq ,Pfizer ,Amgen ,Ligand Pharmaceuticals Incorporated ,Ligand Pharmaceuticals Enter ,Ligand Pharmaceuticals ,Baxter International ,Exchange Commission ,Ovid Therapeutics Inc ,Gilead Sciences ,Soticlestat Royalties ,Milestones Extending Ovid ,Cash Runway ,Chief Business ,Financial Officer ,Dravet Syndrome ,New York Based ,Quarterly Report ,Private Securities Litigation Reform Act ,

comparemela.com © 2020. All Rights Reserved.